Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
Depression is a common mental disorder. Its treatment with selective serotonin reuptake inhibitors (SSRIs) is effective only in a fraction of patients, and pharmacoresistance is increasing steadily. Intranasal (IN) drug delivery to the brain stands out as a promising strategy to improve current ther...
Saved in:
Main Authors: | Soraia Silva (Author), Joana Bicker (Author), Carla Fonseca (Author), Nuno R. Ferreira (Author), Carla Vitorino (Author), Gilberto Alves (Author), Amílcar Falcão (Author), Ana Fortuna (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
by: Soraia Silva, et al.
Published: (2021) -
Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
by: Maria Aquino, et al.
Published: (2023) -
Intranasal Drug Delivery: How, Why and What for?
by: Anaísa Pires, et al.
Published: (2009) -
Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
by: Rui Silva, et al.
Published: (2023) -
Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
by: Rui Silva, et al.
Published: (2020)